Is Roux-en-Y Feeding Jejunostomy a Safe and Effective Operation in Children? A Systematic Review Exploring Outcomes

Paul S Cullis1,2, Rheanan E Buckle3, Paul D Losty4,5

  • 1Department of Surgical Paediatrics, Royal Hospital for Children and Young People, Edinburgh.

Insights

Roux-en-Y jejunostomy (REYJ) can establish enteral autonomy in children but carries significant risks. Complications affect up to 50% of patients, with a 23% mortality rate, necessitating careful patient counseling.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Nutritional Support

Background:

  • Roux-en-Y jejunostomy (REYJ) is utilized for feeding in pediatric patients with foregut dysmotility or severe gastro-esophageal reflux disease (GERD).
  • Concerns exist regarding the safety and efficacy of REYJ in this vulnerable population.
  • Evaluating outcomes is crucial for determining its suitability in achieving enteral autonomy.

Purpose of the Study:

  • To systematically review the outcomes of Roux-en-Y jejunostomy (REYJ) in children.
  • To assess the safety and efficacy of REYJ for achieving enteral autonomy in pediatric patients with complex nutritional needs.

Main Methods:

  • A PRISMA-adherent systematic review was conducted, searching Embase, CINAHL, and Medline databases.
  • Methodological quality was assessed using the Methodological Index for Non-randomized Studies (MINORS) and a bespoke system.
  • Ten studies involving 164 pediatric patients were included.

Main Results:

  • The methodological quality of included studies was generally poor.
  • Most patients achieved enteral autonomy, though data on feeding progression and length of stay were inadequate.
  • Seventy-six complications were reported, including peristomal leakage, internal hernia/volvulus, and surgical site infections. Thirty-eight patients died during follow-up.

Conclusions:

  • Roux-en-Y jejunostomy (REYJ) can achieve enteral autonomy in children.
  • However, up to 50% of patients experience complications, and 23% die during follow-up, often due to comorbidities.
  • Parents and caregivers require thorough counseling regarding the risks and benefits of REYJ.
Abstract

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
341
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
537
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
186
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
15
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
24
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451